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Abstract  
BACKGROUND: To our knowledge, the correlation between ultrasonographic enthesopathy and severity in 
psoriatic arthritis (PsA) has been done before. However, the correlation between ultrasonography of enthesopathy 
and the Psoriatic Arthritis Disease Activity Score (PASDAS) have not been done. 
AIM: To compare the results of ultrasonographic enthesopathy of foot and PASDAS in PsA. 
MATERIALS AND METHODS: A total of 65 PsA patients were involved and divided into two groups. The first 
group of 35 active PsA and the second group of 30 ages and sex matched inactive PsA as a control group were 
recruited in this study. Both groups were evaluated by examination, radiological findings and ultrasonography. 
RESULTS: Of 70 entheses in 35 active PsA patients, the most entheseal abnormalities were tender plantar fascia 
(18.5%), tender Achilles tendon (37.8%). PASDAS was a direct highly significant correlated with plantar fascia 
and Achilles tendon thickness in in active PsA (r = 0.823 and r = 0.796, p < 0.001 respectively).  
CONCLUSION: Musculoskeletal US is an accurate and low-cost method for assessment of enthesopathy with 
significant correlation to disease activities in psoriatic arthritis. 
 
 
 
 
 
 
Introduction 
 
To our knowledge, the correlation between 
ultrasonographic enthesopathy and severity in 
psoriatic arthritis (PsA) has been done before. 
However, the correlation between ultrasonography of 
enthesopathy in the foot and the Psoriatic Arthritis 
Disease Activity Score (PASDAS) has not been done. 
Thus, our aim is to compare the results of 
ultrasonographic enthesopathy of foot and PASDAS in 
PsA. 
Psoriatic arthritis is rheumatic disease 
associated with psoriasis and included among 
seronegative forms of spondyloarthropathy. It is 
characterized clinically by the involvement of joints, 
tendons, and entheses, that is, sites of insertion of 
tendons, ligaments, and articular capsules into bone 
[1]. The functioning entheses dissipate stress over a 
wide area, including the insertion, immediately 
adjacent tendon and adjacent bone [2]. 
Heel pain is a common sign of psoriatic 
arthritis, and ten percent of psoriatic arthritis sufferers 
heel pain as a significant symptom [3]. In particular, 
Achilles tendinitis is fairly common in psoriatic arthritis 
and may associate with severe foot pain and difficulty 
walking with swelling and tenderness along the course 
of the tendon and at the calcaneal insertion [4]. The 
Leeds Enthesitis Index (LEI) is one of clinical 
assessment of disease activity were commonly used 
as enthesitis Index in psoriatic arthritis [5]. 
Musculoskeletal ultrasonography is thought to 
be the gold standard imaging technique for assessing 
tendons, inexpensive, and readily demonstrates 
superficial tissue such as entheseal and tendon 
abnormalities, fluid collections, soft tissue lesions as 
well as bone surface lesions [6]. Recently, PASDAS is 
new composite disease activity measurement for the 
psoriatic arthritis and it is a composite index based on 
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patient (PtGA) and physician (PhGA) global VAS 
scores, tender (SJC66) and swollen (SJC68) joint 
counts, dactylitis and enthesitis, health-related QOL 
(SF36 − PCS), and CRP level [7]. 
Also, our aim of the present study was to 
study ultrasonographic evaluation of entheseal 
abnormalities in the foot including Achilles tendon, 
and plantar fascia insertions in the calcaneus in active 
and inactive PsA patients and moreover, to compare 
the results of ultrasonographic enthesopathy of the 
foot in the foot with PASDAS in active PsA patients. 
 
 
Patients and Methods 
 
A total of 65 PsA patients were involved and 
divided into two groups. The first group of thirty-five 
patients with active PsA were recruited from 
outpatient clinics, dermatology department together 
with the second group of thirty age and sex matched 
inactive PsA patient as a control group. Some patients 
underwent treatment with DMARD and biologic 
agents. CASPAR (classification of psoriatic arthritis 
study group) criteria for the classification of psoriatic 
arthritis were used [8]. A total of 70 entheses in the 
study group and 60 entheses in the control group 
were evaluated by clinical, radiological examination 
and ultrasonography of bilateral Achilles tendon and 
the plantar fascia insertions in the calcaneus. 
Inclusion criteria for cases were age more 18 
years; diagnosis of chronic plaque psoriasis lasting 
more one year; the presence of any clinical signs and 
symptoms of articular involvement and enthesopathy. 
Exclusion criteria for cases were rheumatoid arthritis, 
crystal induced arthritis, osteoarthritis, Reiter’s 
syndrome, obvious inflammatory bowel disease, other 
active inflammatory skin conditions, metabolic, and 
endocrine disorders, severe comorbidities, recent 
serious infection and drug- induced tendinopathy e.g. 
fluoroquinolones and retinoid. All patients gave their 
informed verbal voluntary consent to use the recorded 
data in their follow up sheets and to perform US 
assessment according to the protocol approved by the 
local ethics committee and in accordance with the 
ethical standards of the Helsinki declaration. 
Clinical and laboratory assessment of disease 
activity included the following instruments: clinical 
examination of bilateral Achilles tendon, and plantar 
fascia insertions in the calcaneus; a measure of 
acute-phase response (CRP and ESR); the Leeds 
Enthesitis Index (LEI) and the Psoriatic Arthritis 
Disease Activity Score (PASDAS) [7]. 
Measures of enthesitis included the Leeds 
Enthesitis Index (LEI) score which consisted of 
bilaterally six sites: right and left Achilles tendon 
insertions, medial femoral condyles superior to the 
joint line, and lateral epicondyles of the humerus at 
the common extensor origin. The pressure was 
exerted at the enthesis sufficient to blanch the finger 
nail of the examiner (approximately 4 Kg). In addition, 
the examiner assessed the presence of soft-tissue 
swelling at the enthesis [5]. 
PASDAS was done and included a composite 
index based on patient and physician global VAS 
scores, tender and swollen joint counts, dactylitis and 
enthesitis, health-related QOL, and CRP level. The 
PASDAS was calculated from the following variables: 
patient global VAS (rescaled from 0–10 to 0–100), 
physician global VAS (rescaled from 0–10 to 0–100), 
66 swollen joint count, 68 tender joint count, CRP 
level (rescaled from mg/dl to mg/liter), enthesitis 
(measured in GO- REVEAL as modified Maastricht 
Ankylosing Spondylitis Enthesitis Score and rescaled 
to a 0–6 range by multiplying by a factor of 6/15 for 
this analysis), tender dactylitis count (the GO-
REVEAL study scored each digit from 0–3 and these 
were recoded to 0–1, where any score > 0 equaled 1), 
and, finally, the physical component summary (PCS) 
scale of the short form 36 health survey (SF-36) [7]. 
The PASDAS is computed by the following equation: 
PASDAS = (((0. 18 √ (PhGA) + 0.159 √ (PtGA) − 
0.253 √ (SF36 − PCS) + 0.101 lognat (SJC66 + 1)) + 
0.048 × lognat (SJC68 + 1)) + 0.23 × lognat (Leeds 
enthesitis index + 1)) + 0.37 × lognat (tender dactylitis 
count + 1) + 0.102 × lognat (CRP + 1) + 2 × 1.5.  The 
physical component summary (PCS) scale of the 
Short Form 36 health survey (SF-36) was done [7, 9]. 
Laboratory assessments including a complete 
blood cell count, erythrocyte sedimentation rate (ESR) 
and C-reactive protein (CRP) levels were done. Also, 
Rheumatoid Factor (RF) titers were determined. ESR 
was measured by the standard Westergren method 
(mm/h). CRP levels were measured by standard 
nephelometry (mg/l). RF was measured by enzyme-
linked immunosorbent assay (ELISA) and results are 
expressed in titers of 1/40 and higher. Lateral 
radiographs of heels were obtained using 
standardized techniques as well as US scans. 
Measuring and detection of enthesitis by 
ultrasonography evaluations of bilateral Achilles 
tendon and plantar fascia insertions in the calcaneus 
in both groups were performed. Ultrasound (US) 
examinations were carried out with patients in the 
prone position with their feet hanging off the 
examination table in a neutral position (90 degrees of 
flexion) using a Hitachi Aloka Ultrasound Machine (the 
Hitachi Aloka medical, Ltd, Tokyo, Japan) using a 10–
15 MHz linear transducer. In all patients, we 
predominantly used 90° flexion of the feet during 
examination of bilateral Achilles tendon and plantar 
fascia insertions. The longitudinal and transverse 
planes were used to assess the enthesis. The mean 
values of three measurements were used for 
statistical analysis. All of the sonographic 
examinations were performed by a radiologist who 
was expert in soft tissue sonography. 
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Statistical analysis 
Study data were analysed using the SPSS 
(Statistical Package from Social Science Program) 
(version15.0) statistical package. The normality of the 
population was done during statistical analysis. The 
Student’s t test indicates the magnitudes of the 
differences of means ± SD and therefore the 
magnitude of the observation. Thus, the unpaired t-
test was used to assess the difference between 
patients and control subjects. Before data analysis, 
the level of significance was established at P < 0.05. A 
p value of < 0.05 was used as significance. 
We used SPSS (Statistical Package from 
Social Science Program) version 15.0 for data 
processing (SPSS Inc, Chicago, IL, USA). 
Quantitative data were presented as mean (± SD). 
Correlation between variables was done, and Pearson 
correlation coefficient was calculated. All tests were 2-
tailed and considered statistically significant at p < 
0.05. 
 
 
Results 
 
There was significant differences between 
ESR, CRP and US thickness of plantar fascia (mm) 
and Achilles tendon (mm) between active PsA 
patients and controls (p< 0.05). Moreover, there were 
a significant difference PASDAS between active PsA 
patients and controls (p< 0.05) (Table 1). 
Table 1:   Demographic, clinical and laboratory findings in 35 
patients with active PsA and 30 inactive PsA as control group 
Characteristics 
(Mean ± SD) n (%) 
Active PsA) 
(  N = 35) 
Inactive PsA 
(  N = 30) 
p –value 
Age (years) 
Gender ( male /female)  
Disease duration (years)  
BMI (kg/m^2) 
44.77± 10.11 
20/15 
8.18 ± 3.27 
26.42 ± 4.80 
46.30 ± 12.6 2 
17/13 
8.00 ± 2.49 
24.90 ± 4.67 
- 
- 
- 
- 
Clinical presentations of arthritis, n (%) 
Low back pain 
Oligoarthritis 
Polyarthritis 
- 
13/35 (37.1%) 
21/35 (60.0%) 
7/35 (20.0%) 
- 
8/ 30 (26.7%) 
16/ 30 (53.3%) 
6/ 30 (20.0%) 
- 
- 
- 
Visual Analogue Scale (VAS) 
Patient global VAS scores(range 0–100) 
Physician global VAS scores(range 0–100) 
- 
40.57 ± 16.67 
29.68 ± 7.53 
- 
26.20 ± 7.74 
17.19 ± 4.63 
- 
p<0.05 S 
p<0.05 
Peripheral joint counts 
68 tender joint count (range 0-68) 
66 swollen joint count (range 0-66) 
- 
42.80 ± 12.80 
29.16 ± 3.62 
- 
17.93 ± 5.94* 
17.16 ± 5.06* 
- 
p<0.05 S 
p<0.05 S 
Enthesis/dactylitis counts 
Leeds Enthesitis Index range 0–6) 
Dactylitis count (range 0–20) 
- 
3.28 ± 1.52 
8.94 ± 480 
- 
2.30 ± 0.83* 
6.43 ± 2.40* 
- 
p<0.05 S 
p<0.05 S 
Health-related quality of life and functions: 
(the mean ± SD ) , SF36 PCS  (range 0–
100) 
- 
35.11 ± 16.07 
- 
7.92 ± 6.74* 
- 
p<0.05 S 
Acute phase reactants 
ESR (mm/hour) 
CRP (mg/dl) 
- 
42.14 ±16.02 
19.08 ± 8.07 
- 
8.20 ± 5.67* 
7.33 ± 6.46* 
- 
p<0.05 S 
p<0.05 S 
PASDAS (the mean ± SD ) 3.50 ± 0.81 1.92 ± 0.48* p<0.05 S 
US thickness of Plantar fascia (mm) 4.63 ± 1.16 3.62 ± 0.51* p<0.05 S 
US thickness of Achilles tendon  (mm) 5.42 ± 1.13 4.03 ± 0.36* p<0.05 S 
Medications, n (%) 
NSAID 
Methotrexate (7.5–17.5 mg/week) 
Anti-tumor necrosis factor 
Combined therapy 
- 
32/ 35 (91.4%) 
30 /35 (85.7%) 
4/ 35 (11.4%) 
3/ 35 (8.6%) 
 
21/ 30 (70.0%) 
20/ 30 (66.7%) 
2/ 30 (6.7%) 
3/ 30 (10.0%) 
- 
- 
- 
- 
- 
** p < 0.0001 = highly significant,*p<0.05=significant. p>0.05=non-significant (NS). ESR: 
erythrocyte sedimentation rate; CRP: C-reactive protein; PASDAS: Psoriatic Arthritis 
Disease Activity Score, SF36 PCS: The Short Form 36 Scale (SF-36) health survey -
Physical component scale of SF36. 
 
Of 70 entheses in 35 active PsA patients, the 
most entheseal abnormalities were tender plantar 
fascia insertion (18.5%), tender Achilles tendon 
insertion (37.8%) , incidence of US tendon thickening 
of plantar fascia insertion (55.5%), incidence of US 
Tendon thickening of Achilles tendon insertion 
(34.5%) , osteophyte (spur) of plantar fascia insertion 
(12.6%) and osteophyte (spur) of Achilles tendon 
insertion (16.1%) (Table 2, Figure 1).  
Table 2: Clinical, radiological findings and ultrasonography of 
plantar fascia insertion and Achilles tendon insertion in 
calcaneus in 35 patients with active PsA patients 
Achilles tendon insertion 
in calcaneus 
(n = 70 entheses ) 
Plantar fascia insertion in 
calcaneus 
(n = 70 entheses ) 
Data, n (%)    
- 
33/70 (37.9%) 
3/70 (3.4%) 
- 
17/70 (19.5%) 
0/70 (0 %) 
Clinical presentations, n (%)    
 Tender  
 Swollen  
 
- 
14/70 (16.1%) 
2/70 (2.3%) 
- 
11/70 (12.6%) 
3/70 (3.4%) 
Pain x-ray of heel, n (%)   
 Osteophyte (spur)  
 Erosions 
- 
10/70 (34.5%) 
13/70 (14.9%) 
2/70 (2.3%) 
2/70 (2.3%) 
- 
16/70 (55.2%) 
9/70 (10.3%) 
2/70 (6.9%) 
0/70 (0%) 
Ultrasonography, n (%)    
 US tendon  thickened* 
 US Enthesophyte  
 US Bone erosion  
 US Bursitis 
*Achilles tendon >5.29 mm, plantar aponeuroses >4.4 mm; . ** p< 0.0001= highly 
significant,*p<0.05=significant. 
 
 
In our study, we did not find power Doppler 
signal entheseal in PsA patients. PASDAS was a 
direct significant correlation with Leeds Enteritis Index 
score in active PsA patients (r = 0. 0.452, p< 0.05).  
  
Figure 1: Linear regression correlation (r-) of PASDAS and plantar 
fascia thickness (mm) in active psoriatic arthritis (r =0.823**, p< 
0.001) (left). Figure 2: Linear regression correlations (r-) of PASDAS 
and Achilles tendon thickness in active psoriatic arthritis (r =0.796**, 
p< 0.001) (right) 
 
Moreover, PASDAS was a direct highly 
significant correlation with the thickness of Plantar 
fascia and the thickness of Achilles tendon in active 
PsA patients (r = 0. 823, p< 0.001 and r = 0. 796, p < 
0. 001 respectively) (Table 3, Figures 2). 
Table 3: Correlation (r) between PASDAS and Leeds Enthesitis 
Index as well as the US thickness of both plantar fascia and 
Achilles tendons (mm) in active PsA patients 
 PASDAS ( r  and  p ) 
Leeds Enthesitis Index 
 
r =0.452* ,  p< 0.05 S 
The plantar fascia thickness (mm)  
 
r =0.823** , p< 0.001 HS 
The Achilles tendon thickness (mm)  
 
r =0.796** , p< 0.001 HS 
** p< 0.001= Correlation is highly significant, *p<0.05= Correlation is significant. Psoriatic 
Arthritis Disease Activity Score (PASDAS). 
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Discussion 
 
Limitations in clinical assessment of the 
entheses have prompted the use of ultrasound (US) to 
detect the presence of enthesitis. Imaging techniques 
such as the US have been increasingly used in 
psoriatic arthritis (PsA) providing additional clues to 
severity and the pathogenesis of this peripheral, axial 
disease. In the last few years, composite measures of 
disease activity in PsA have been developed. 
PASDAS was better able to discriminate between high 
and low disease activity [7]. Acquacalda E et al. [10] 
found a high frequency of US enthesitis in psoriasis 
patients, with or without musculoskeletal symptoms. 
Also, enthesitis is common in PsA and considered 
important by affected patients [11]. 
  
Figure 2: The ultrasound of left heel showed the plantar fascia 
thickness (4.5 mm) (left). The ultrasound of right tendoachilis 
showed the Achilles tendon thickness (4 mm) (right) 
 
In the present study, of 70 entheses in 35 
active PsA patients, the most entheseal abnormalities 
were tender plantar fascia insertion (18.5%), tender 
Achilles tendon insertion (37.8%), US tendon 
thickening of plantar fascia insertion (55.5%), US 
Tendon thickening of Achilles tendon insertion 
(34.5%), osteophyte (spur) of plantar fascia insertion 
(12.6%) and osteophyte (spur) of Achilles tendon 
insertion (16.1%). Moreover, we found a significant 
difference of ESR, CRP, US thickness of plantar 
fascia, US thickness of Achilles tendon, PASDAS 
between active PsA patients and controls (p < 0.05). 
In our study, we did not find power Doppler signal 
entheseal in PsA patients. 
Similar findings were reported by Galluzzo E 
et al. [4] who found that 71% of the 31 PsA patients 
showed sonographic features of tendon involvement 
in 27 cases of plantar fasciitis in 16 patients and 11 
cases of Achilles tendon enthesopathy in 6 patients. 
The Achilles tendon is among the most frequent sites 
of enthesopathic involvement in psoriatic arthritis, 
producing heel pain, and difficulty walking. Also, heel 
pain is a common sign of psoriatic arthritis with ten 
percent of psoriatic arthritis sufferers reporting heel 
pain as a significant symptom [3]. 
Furthermore, Naredo E et al. [12] 
demonstrated that US enthesopathy was significantly 
more frequent in psoriatic patients than in controls in 
11.6% of entheses in the psoriasis group and 5.3% of 
entheses in the control group. Similarly, Yang Q et al. 
[13] found that enthesitis was present in 26.8% of the 
patients. Also, Kane D et al. [14] found that 38% had 
peripheral enthesopathy; 12% had plantar fasciitis; 
6% had Achilles tendonitis; 37 (29%) had dactylitis of 
digits; 2% had tenosynovitis of the wrist; 10% had 
inflammatory spine pain. D’Agostino MA et al. [15] 
reported that the commonest sites of enthesopathy 
involvement in PsA are Achilles tendon, plantar fascia, 
patellar tendon and greater trochanter. 
Moreover, De Filippis et al. [16] found that 
entheseal abnormalities, not detected at clinical 
examination, were present ultrasonography in six of 
24 (25%) psoriasis patients. Naredo E et al. [12] 
reported that US enthesopathy was present in 11.6% 
of entheses in the psoriasis group and 5.3% of 
entheses in the control group (P < 0.0005). Ozcakar et 
al. [17] reported a significantly higher mean thickness 
of the Achilles tendon measured by the US in 30 
psoriatic patients than in 20 healthy controls. De 
Simone et al [18] reported that ultrasonographic 
enthesopathic abnormalities were found in 11 of 15 
psoriatic arthritis and involvement of the Achilles 
tendon found in 35 of 59 psoriatic patients, whereas 
clinical evaluation showed Achilles tendinitis in 18 
(30.5%) of the 59 psoriatic patients and Achilles 
sonographic abnormalities in 35 of 59 psoriatic 
patients (59.2%). Astorri D et al. [19] reported that 
power Doppler ultrasound allows detecting structural 
and inflammatory abnormalities of enthesis in early 
PsA patients. But in the present study, we did not find 
power Doppler signal entheseal in PsA patients in 
present study. 
In the present study, PASDAS was a direct 
significant correlation with Leeds Enteritis Index score 
(r = 0.452, p < 0.05) in active PsA patients. Moreover, 
PASDAS was a direct highly significant correlation 
with the thickness of plantar fascia and the thickness 
of Achilles tendon in active PsA patients, (r = 0. 823, p 
< 0.001 and r = 0. 796, p < 0. 001 respectively). 
Similar findings were reported by Girolomoni 
G and Gisondi P [20] who found that monitoring of 
psoriasis patients has revealed that a higher baseline 
score for enthesitis may be associated with a more 
severe psoriasis outcome and nine patients with more 
severe clinical psoriasis outcome had a significantly 
higher baseline the Glasgow Ultrasound Enthesitis 
Scoring System (GUESS) score (9.29 vs. 4.25; P < 
0.001) and a significantly higher baseline PASI score 
(14.5 vs. 3.8; P < 0.002) compared with the patients 
with a good clinical psoriasis outcome . But, no 
significant differences between the two groups were 
found for disease duration, age, waist circumference, 
BMI, or comorbid diabetes. Furthermore, Aydin SZ et 
al. [21] reported that psoriasis patients (with or without 
arthritis) were more likely to express higher 
inflammation-related enthesopathy scores and the 
psoriatic arthritis patients had higher ultrasound 
enthesopathy scores than psoriasis patients. 
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Moreover, Gisondi et al. [22] reported that enthesitis 
score, as measured by the GUESS, correlates with 
BMI among patients with psoriasis alone. 
In disagreement with our findings, Gisondi et 
al. [22] and Gutierrez et al. [23], did not find an 
association between most power Dopper ultrasound 
abnormalities of lower limbs and psoriasis severity, 
psoriasis duration. Interestingly, the presence of 
enthesopathy was directly correlated with age, body 
mass index, and waist circumference. However, 
Gisondi et al. [22] found a significantly higher mean 
GUESS score in psoriatic patients as compared with 
controls. By contrast, Gutierrez et al. [23] found 
significantly more US signs of enthesopathy and 
higher GUESS in the lower limbs of psoriatic patients 
as compared with healthy controls. Interestingly, the 
presence of enthesopathy was directly correlated with 
age, body mass index, and waist circumference and 
not with the duration and severity of psoriasis. 
However, Ash ZR et al. [24] showed that no link 
between the severity of psoriasis and enthesitis was 
evident. Our possible explanation of differences of 
correlation between enthesitis scores and severity of 
psoriasis from other authors may be due to different 
methods of severity assessment of enthesitis and 
psoriasis enthesitis in psoriatic arthritis. 
Although the mechanism of enthesitis in PsA 
remains unclear, the roles of environmental, 
mechanical stress, immunologic and genetic factors 
have been studied. Gisondi et al. [22] reported the 
underlying causes of the enthesitis might be due to 
increased mechanical stress on the entheses of the 
lower limbs due to heavier weight, although obesity is 
also associated with systemic inflammation and high 
levels of proinflammatory cytokines. De Simone et al. 
[18] showed that the most common disorder was 
degenerative lesions of tendinitis with or without 
micro-calcification in psoriatic arthritis. Also, a 
hypothesis in PsA is that enthesitis arises at sites of 
high shear and compression forces, with the additive 
interaction between mechanical stress, microtrauma, 
and tissue repair mechanisms and bacterial molecules 
variably leading to inflammation [25]. 
Mease P [26] suggested that pathogenetic 
studies of PsA emphasize several areas: 1) 
immunologic factors including T cells and the 
Interleukin-23/17 pathway, 2) abnormal bone 
remodelling that involves bone erosion and bone 
proliferation; a unique pattern is seen in PsA, 3) 
genetics and 4) environmental factors. Moreover, 
mechanism of enthesitis in PsA may be explained by 
Coates LC et al. [27] who described that MRI and to a 
lesser extent the US allow visualization of localization 
of inflammatory change at the juxta-articular entheses 
suggests this as the primary site of inflammation. 
In conclusion, musculoskeletal US is an 
accurate and low-cost method for assessment of 
enthesopathy with significant correlation to disease 
activities in psoriatic arthritis patients. A possible 
explanation of limitation of the present study is the low 
size of our population. Further studies would be 
interesting to validate our data in the large size of the 
population. 
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